Oxymorphone clinical trials
Also written Opana.
How each study uses Oxymorphone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 2 Apr 1959 · OPANA · NDA 011707 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2013 | 1 |
| 2016 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 18 · Other 3
Endo Pharmaceuticals (13) · Sandoz (2) · Icahn School of Medicine at Mount Sinai (2) · MedVadis Research Corporation (1) · Vanderbilt University (1) · Roxane Laboratories (1) · Endo USA Inc., a Keenova Therapeutics Company (1)
Often tested with
Tested in the same studies.
Propofol (1) · Sevoflurane (1) · Isoflurane (1) · Desflurane (1) · Scopolamine (1) · Droperidol (1) · Haloperidol (1) · Dexamethasone (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Oxymorphone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 21
- Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant PainCompletedPhase 3Endo PharmaceuticalsNCT00226421Written as Oxymorphone Extended Release
- Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant PainCompletedPhase 3Endo PharmaceuticalsNCT00225797Written as Oxymorphone Extended Release
- Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive FunctioningCompletedPhase 4MedVadis Research CorporationNCT00930943Written as Oxymorphone ER
- Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsTerminatedPhase 3Endo PharmaceuticalsNCT02687451Written as Oxymorphone HCl
- Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsCompletedPhase 3Endo PharmaceuticalsNCT01210352Written as oxymorphone HCl
- Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced ChildrenSuspendedPhase 3Endo PharmaceuticalsNCT04681027Written as Oxymorphone hydrochloride (HCl)
- Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric SubjectsTerminatedPhase 3Endo PharmaceuticalsNCT00765856Written as Oxymorphone ER
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNot applicableVanderbilt UniversityNCT02625181Written as Oxymorphone
- Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.CompletedPhase 3Endo PharmaceuticalsNCT00801398Written as Oxymorphone IR
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted ConditionsCompletedPhase 1Roxane LaboratoriesNCT01210638Written as Oxymorphone
- Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)CompletedPhase 4Endo PharmaceuticalsNCT00955110Written as Oxymorphone ER
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed ConditionsCompletedPhase 1SandozNCT00857142Written as oxymorphone hydrochloride
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted ConditionsCompletedPhase 1SandozNCT00857428Written as oxymorphone
- A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)CompletedNot applicableIcahn School of Medicine at Mount SinaiNCT00580294Written as Oxymorphone
- Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric SubjectsWithdrawnPhase 3Endo PharmaceuticalsNCT01206907Written as oxymorphone IR
- Oxymorphone Extended Release in Patients With Cancer or Neuropathic PainCompletedPhase 3Endo PharmaceuticalsNCT00911261Written as Oxymorphone Extended Release
- Post-operative Efficacy and Safety StudyCompletedPhase 3Endo USA Inc., a Keenova Therapeutics CompanyNCT00904085Written as Oxymorphone IR
- Open Label Assessment of Long-Term Safety and UtilityCompletedPhase 3Endo PharmaceuticalsNCT00904449Written as Oxymorphone ER
- Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic PainCompletedPhase 3Endo PharmaceuticalsNCT00911287Written as Oxymorphone extended release
- A Pilot Study of Ultra Rapid Opioid Rotation and Titration of OxymorphoneStatus unknownNot applicableIcahn School of Medicine at Mount SinaiNCT00945919Written as Oxymorphone ER
See all 21 studies that test Oxymorphone →
Given beside what is tested · 1 — Oxymorphone is usual care or a partner of the new treatment
Codes
What other systems call Oxymorphone · ClinicalTrials.gg INT007942
- MeSH (NLM) D010111OxymorphoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 9VXA968E0COXYMORPHONEConfirmed FDA, NLM, Wikidata
- RxNorm 7814Confirmed FDA, Wikidata
- Wikidata Q423380oxymorphoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29314OxymorphoneOne source FDA
- DrugBank DB01192One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D010111 | Oxymorphone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 9VXA968E0C | OXYMORPHONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 7814 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423380 | oxymorphone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29314 | Oxymorphone | One source FDA |
| DrugBank | DB01192 | — | One source Wikidata |
Also registered as oxymorphone hydrochloride (UNII 5Y2EI94NBC · RxNorm 82064).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.